e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Understanding the immunopathology that underlies airway obstructive diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bacterial lysates in the prevention of asthma exacerbations in uncontrolled asthma: the Breathe study
G. de Boer (Rotterdam, Netherlands), G. Braunstahl (Rotterdam, Netherlands), R. Hendriks (Rotterdam, Netherlands), G. Tramper (Rotterdam, Netherlands)
Source:
International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Session:
Understanding the immunopathology that underlies airway obstructive diseases
Session type:
Poster Discussion
Number:
5008
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. de Boer (Rotterdam, Netherlands), G. Braunstahl (Rotterdam, Netherlands), R. Hendriks (Rotterdam, Netherlands), G. Tramper (Rotterdam, Netherlands). Bacterial lysates in the prevention of asthma exacerbations in uncontrolled asthma: the Breathe study. 5008
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Bacterial lysate therapy for the prevention of wheezing episodes and asthma exacerbations: a systematic review and meta-analysis
Source: Eur Respir Rev, 29 (158) 190175; 10.1183/16000617.0175-2019
Year: 2020
Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Bacterial burden in rhinovirus-induced asthma exacerbations
Source: Lung Science Conference 2015
Year: 2015
Emergency visits for asthma: asthma exacerbations or poor asthma control?
Source: Eur Respir J 2004; 24: Suppl. 48, 598s
Year: 2004
Asthma control and exacerbation rate with omalizumab in Italian patients with severe allergic asthma: PROXIMA study
Source: International Congress 2017 – Asthma management
Year: 2017
Acute severe asthma: evidence-based management of asthma exacerbations
Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond
Year: 2008
LSC Abstract – Bacterial burden in rhinovirus-induced asthma exacerbations
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015
Real-life effectiveness of omalizumab in patients with severe persistent allergic asthma: the PERSIST study
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009
Could montelukast reduce asthma exacerbations?
Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008
Increase in α-defensins during rhinovirus-induced experimental asthma exacerbations
Source: Eur Respir J 2006; 28: Suppl. 50, 154s
Year: 2006
Montelukast reduces viral-induced asthma exacerbations: the PREVIA study
Source: Eur Respir J 2004; 24: Suppl. 48, 212s
Year: 2004
The prevention of virus-induced exacerbation of bronchial asthma in children
Source: Annual Congress 2012 - Treating childhood asthma
Year: 2012
Viral and bacterial infections in exacerbations of asthma and COPD
Source: Annual Congress 2004 - PG9 - The role of infection in airway inflammation and exacerbation
Year: 2004
COPD exacerbations: impact and prevention
Source: Breathe 2013; 9: 434-440
Year: 2013
Asthma phenotypes: do cough and wheeze predict exacerbations in persistent asthma?
Source: Eur Respir J, 50 (6) 1701366; 10.1183/13993003.01366-2017
Year: 2017
Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Allergic asthma: determinants of asthma control
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008
Prevention and management of exacerbations of asthma and COPD
Source: Annual Congress 2010 - Severe exacerbations in asthma and COPD: new causes, mechanisms and models of care
Year: 2010
Omalizumab reduces asthma exacerbations and oral corticosteroid use in patients with severe allergic asthma: a systematic review of observational studies
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept